The company
Bright Minds Biosciences Inc.
DRUG · Nasdaq
DRUG stood above a rising 150-day average in 32 of the last 52 weekly readings, and has been out of that trend for the last 20 weeks. It is 29.2% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).
Statistics
- Rotation
- Not moving yet
- Weeks in an uptrend
- out for 20
- Industry in uptrend
- 15% -17 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $19.6M
- Officials’ trades on record
- 0
- Institutions holding
- 100 (+10)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 32 of 52 weeks.
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Cormorant Asset Management, LpOther | sold | 109,331at $89.50 | 28 Apr 2026filed 30 Apr 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| Jupiter Topco LLCnew · filed 14 Aug 2026 | 1,349,107$94.8M | +1,349,107 |
| Cormorant Asset Management, LPreduced · filed 14 Aug 2026 | 900,000$63.2M | -159,331−15.0% |
| BlackRock, Inc.added · filed 7 Aug 2026 | 686,184$48.2M | +64,251+10.3% |
| Vivo Capital, LLCunchanged · filed 14 Aug 2026 | 557,172$39.1M | 00.0% |
| Vestal Point Capital, LPadded · filed 14 Aug 2026 | 545,000$38.3M | +52,681+10.7% |
| BRAIDWELL LPreduced · filed 14 Aug 2026 | 483,822$34.0M | -55,886−10.4% |
| Driehaus Capital Management LLCadded · filed 14 Aug 2026 | 433,377$30.4M | +862+0.2% |
| Balyasny Asset Management L.P.added · filed 14 Aug 2026 | 345,053$24.2M | +47,895+16.1% |
| ADAGE CAPITAL PARTNERS GP, L.L.C.reduced · filed 14 Aug 2026 | 335,000$23.5M | -160,743−32.4% |
| Point72 Asset Management, L.P.new · filed 14 Aug 2026 | 327,416$23.0M | +327,416 |
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.